Analgesic formulations having enhanced therapeutic activity
US3936528A · kind A · utility
4Cited by
3References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 13, 1974 |
| Grant date | Feb 3, 1976 |
| Priority date | — |
| Expiry date | Feb 13, 1994 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application describes analgesic formulations including d 2-(6-methoxy-2-naphthyl)propionic acid, or a pharmaceutically acceptable salt or ester thereof, in combination with at least one central nervous system active analgesic compound. Analgesic activity of the combination is greater than that obtained with either of the components alone, thus demonstrating enhanced analgesia which can be obtained therewith.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.